2018. Maintenance of Response With Guselkumab for up to 3 Years’ Treatment in the Phase 3 VOYAGE 1 Trial of Patients With Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine. 2, (Dec. 2018), S90. DOI:https://doi.org/10.25251/skin.2.supp.91.